Compass Therapeutics
Total Raised
$132.58MInvestors Count
19Deal Terms
1Funding, Valuation & Revenue
9 Fundings
Compass Therapeutics has raised $132.58M over 9 rounds.
Compass Therapeutics's latest funding round was a Reverse Merger for on June 23, 2020.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
6/23/2020 | Reverse Merger | 1 | ||||
7/12/2018 | Series A - V | |||||
1/8/2018 | Series A - IV | |||||
9/21/2016 | Series A - III | |||||
1/8/2016 | Series A - II |
Date | 6/23/2020 | 7/12/2018 | 1/8/2018 | 9/21/2016 | 1/8/2016 |
|---|---|---|---|---|---|
Round | Reverse Merger | Series A - V | Series A - IV | Series A - III | Series A - II |
Amount | |||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 1 |
Compass Therapeutics Deal Terms
1 Deal Term
Compass Therapeutics's deal structure is available for 1 funding round, including their Series A from July 01, 2015.
Round | Series A |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A |
Compass Therapeutics Investors
19 Investors
Compass Therapeutics has 19 investors. Olivia Ventures invested in Compass Therapeutics's Reverse Merger funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
6/23/2020 | 6/23/2020 | 1 Reverse Merger | Holding Company | Florida | ||
7/1/2015 | 7/12/2018 | 4 Series A, Series A - III (2016), Series A - IV (2018), Series A - V (2018) | Venture Capital | New York | ||
7/1/2015 | 7/12/2018 | 4 Series A, Series A - III (2016), Series A - IV (2018), Series A - V (2018) | Venture Capital | Massachusetts | ||
Venture Capital | New Hampshire | |||||
Corporate Venture | California |
First funding | 6/23/2020 | 7/1/2015 | 7/1/2015 | ||
|---|---|---|---|---|---|
Last Funding | 6/23/2020 | 7/12/2018 | 7/12/2018 | ||
Investor | |||||
Rounds | 1 Reverse Merger | 4 Series A, Series A - III (2016), Series A - IV (2018), Series A - V (2018) | 4 Series A, Series A - III (2016), Series A - IV (2018), Series A - V (2018) | ||
Board Seats | |||||
Type | Holding Company | Venture Capital | Venture Capital | Venture Capital | Corporate Venture |
Location | Florida | New York | Massachusetts | New Hampshire | California |
Compass Therapeutics Acquisitions
1 Acquisition
Compass Therapeutics acquired 1 company. Their latest acquisition was TRIGR Therapeutics on May 13, 2021.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
5/13/2021 | Other | $5M | Acquired | 1 |
Date | 5/13/2021 |
|---|---|
Investment Stage | Other |
Companies | |
Valuation | |
Total Funding | $5M |
Note | Acquired |
Sources | 1 |
Loading...